DS Research

Dermatology Specialists Research

  • Home
  • Who We Are
    • About
    • Meet Nina M. Scott
    • Meet Our Doctors
    • Meet Our Staff
  • Facilities
    • Kentucky Facility
    • Indiana Facility
    • Travel Accommodations
  • Research Studies
    • Enrolling Studies
  • Sponsor/CRO
  • News
  • Contact

DS Research is currently conducting a trial on this medication for the treatment of Eczema!

July 9, 2018 by Sarah Youssif

FDA Approves OLUMIANT® (baricitinib) 2-mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis- click HERE to read more!  

Uncategorized

Could New CBD Cream Could Be Ultimate Cure For Acne?

July 3, 2018 by Sarah Youssif Leave a Comment

Could New CBD Cream Could Be Ultimate Cure For Acne?

Uncategorized

Psoriasis is the most prevalent autoimmune disease in the U.S.

June 20, 2018 by Sarah Youssif Leave a Comment

Psoriasis is not a cosmetic problem. Nearly 60 percent of people with psoriasis reported their disease to be a large problem in their everyday life. DS Research is currently conducting various research studies for the treatment of plaque psoriasis as well as itching that is associated with psoriasis. To learn more about these statistics involving… Read More

Uncategorized

The Latest in Psoriasis Treatment

March 20, 2018 by Sarah Youssif Leave a Comment

In recent years, research into other autoimmune diseases brought new insights about the immune system. It turns out that some of the problems in those conditions are active in psoriasis, as well. The new info brought treatments that target specific areas of your immune system. Called biologics, these drugs launched a new era of psoriasis… Read More

Uncategorized

2017 Saw the Most New Drugs Approved in Over 20 Years

March 1, 2018 by Sarah Youssif Leave a Comment

Click HERE to read more!

Uncategorized

Eskata approved for the treatment of patients with Seborrheic Keratoses that are raised.

December 18, 2017 by Sarah Youssif Leave a Comment

Eskata approved for the treatment of patients with Seborrheic Keratoses that are raised. To read more click HERE

Uncategorized

JANSSEN ANNOUNCES U.S. FDA APPROVAL OF TREMFYA™ (GUSELKUMAB) FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS

November 1, 2017 by Sarah Youssif Leave a Comment

TREMFYA™ is the first and only biologic approved that selectively blocks interleukin (IL)-23. Seven out of ten patients receiving TREMFYA™ achieved at least 90 percent improvement in skin clearance at week 16. Nearly three quarters of TREMFYA™-treated patients demonstrated at least 90 percent clearer skin at week 48. TREMFYA™ demonstrated superior results in skin clearance… Read More

Uncategorized

First Biologic Approved for Moderate to Severe Atopic Dermatitis

April 3, 2017 by Sarah Youssif Leave a Comment

March 28, 2017 – Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab), the first biologic medication for adults with moderate to severe atopic dermatitis (AD) for whom other topical treatments have not worked or are not adv

Uncategorized

Guselkumab Beats Adalimumab for Moderate to Severe Psoriasis

January 30, 2017 by Sarah Youssif Leave a Comment

“Guselkumab Beats Adalimumab for Moderate to Severe Psoriasis”. DS Research has conducted various trials for psoriasis medications. Be sure to check our this article about the effectiveness of Guselkumab for moderate to severe psoriasis. Click here.

Uncategorized

6 Amazing Reasons to Sleep for Skin Health

January 27, 2017 by Sarah Youssif Leave a Comment

Get your beauty sleep! The ZZZs you catch every night can have a profound impact on your skin health. Here’s how.

Uncategorized

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Contact Us

DS Research – Kentucky Location
3810 Springhurst Blvd.
Suite 130
Louisville, KY 40241
O: 502.585.9059
F: 502.585.9708

DS Research – Indiana Location
1005 E. Lewis & Clark Pkwy
Clarksville, IN 47129
O: 502.373.2849
F: 502.373.2872

Interested About Coming To Us? Our doctors are ready to see you now.

  • This field is for validation purposes and should be left unchanged.

dsrtrials

We had a sweet little Valentine visit us today❤️🪴🌹
Tonight we said farewell to one of our amazing coo Tonight we said farewell to one of our amazing coordinators as she starts a heavy semester as a nurse practitioner student. We are so happy and excited for her and very glad we were all able to get together one last time. Thank you Megan for all you have done! We will miss you.
DS Research is hiring! Call us today for more info DS Research is hiring! Call us today for more information regarding our open positions | 502.585.9059 ✨
Studies are filling up! Call us today for more inf Studies are filling up! Call us today for more information regarding our enrolling studies ✨

Rosacea | Acne | Atopic Dermatitis | Prurigo Nodularis | Alopecia

KY 502.585.9059 | IN 502.373.2849
Load More... Follow on Instagram

Copyright © 2022 DS Research :: Dermatology Specialists Research

  • Facebook
  • Instagram
  • LinkedIn
  • Pinterest
  • Twitter